Medarex, Inc. (NASDAQ:MEDX.DL)
CAPS Rating:
A biopharmaceutical company developing therapeutic products for cancer, inflammation, autoimmune disorders and other life-threatening and debilitating diseases based on its proprietary technology.
RSS Headlines
Fool UK